LivaNova(LIVN)

Search documents
LivaNova(LIVN) - 2021 Q4 - Annual Report
2022-03-01 19:43
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 20 Eastbourne Terrace, London, United Kingdom, W2 6LG (Address of principal executive of ices) ....................... (Zip Code) Registrant's telephone number, including area code: (44) (0) 203 325-0660 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trad ...
LivaNova(LIVN) - 2021 Q4 - Earnings Call Transcript
2022-02-23 18:23
Call Start: 08:00 January 1, 0000 8:40 AM ET LivaNova PLC (NASDAQ:LIVN) Q4 2021 Earnings Conference Call February 23, 2022, 8:00 AM ET Company Participants Damien McDonald – Chief Executive Officer Alex Shvartsburg – Chief Financial Officer Matthew Dodds – Senior Vice President of Corporate Development Conference Call Participants Adam Maeder – Piper Sandler Rick Wise – Stifel Mike Matson – Needham & Company Amit Hazan – Goldman Sachs Zach Tuckwell – Jefferies Matthew Taylor – Union Bank of Switzerland Oper ...
LivaNova(LIVN) - 2021 Q4 - Earnings Call Presentation
2022-02-23 15:29
Liva Nova Health innovation that matters 4Q and Full-Year 2021 Earnings Performance February 23, 2022 Safe Harbor 2 Certain statements in this presentation, other than purely historical information, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements include, but are not limited to, LivaNova's plans, objectives, s ...
LivaNova (LIVN) Investor Day 2021 Presentation - Slideshow
2021-12-13 18:11
LivaNova Investor Day 2021 December 7, 2021 Intended for Investor Use Only - Not Intended for Use by Patients or Health Care Professionals Safe Harbor Certain statements in this presentation, other than purely historical information, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements include, but are not limited ...
LivaNova(LIVN) - 2021 Q3 - Earnings Call Transcript
2021-11-06 22:51
LivaNova PLC (NASDAQ:LIVN) Q3 2021 Earnings Conference Call November 3, 2021 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Mike Matson - Needham & Company Adam Maeder - Piper Sandler Anthony Petrone - Jefferies Michael Polark - Baird Scott Bardo - Berenberg Matt Taylor - UBS Operator Good day, ladies and gentlemen and welcome to ...
LivaNova(LIVN) - 2021 Q3 - Earnings Call Presentation
2021-11-03 19:36
Third Quarter 2021 Earnings Presentation November 3, 2021 Charlotte, VNS Therapy Patient Safe Harbor 2 Certain statements in this presentation, other than purely historical information, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements include, but are not limited to, LivaNova's plans, objectives, strategies, fi ...
LivaNova(LIVN) - 2021 Q3 - Quarterly Report
2021-11-03 19:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-37599 LivaNova PLC (Exact name of registrant as specified in its ...
LivaNova(LIVN) - 2021 Q2 - Quarterly Report
2021-07-28 19:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-37599 Registrant's telephone number, including area code: (44) (0) 20 ...
LivaNova(LIVN) - 2021 Q2 - Earnings Call Transcript
2021-07-28 17:18
LivaNova PLC (NASDAQ:LIVN) Q2 2021 Earnings Conference Call July 28, 2021 8:00 AM ET Company Participants Matthew Dodds - SVP, Corporate Development Damien McDonald - CEO Alex Shvartsburg - Interim CFO Lindsey Little - Senior Director, IR Conference Call Participants Rick Wise - Stifel Mike Matson - Needham & Company Adam Maeder - Piper Sandler Michael Polark - Baird Anthony Petrone - Jefferies Matt Taylor - UBS Scott Bardo - Berenberg Company Operator Good day, ladies and gentlemen, and welcome to LivaNova ...
LivaNova(LIVN) - 2021 Q2 - Earnings Call Presentation
2021-07-28 14:47
alth innovation f Second Quarter 2021 Earnings Performance July 28, 2021 Starr, VNS Therapy Patient Safe Harbor 2 Certain statements in this presentation, other than purely historical information, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements include, but are not limited to, LivaNova's plans, objectives, str ...